Topics

New Perioperative Strategies Emerge for High-Risk, Resectable RCC

12:22 EST 4 Dec 2019 | OncLive

The current management of metastatic renal cell carcinoma reflects the progress of medical oncology throughout the past several decades. The standard of care has evolved from cytokine-based therapies to targeted molecular therapies and immune checkpoint inhibitor–based strategies.

Original Article: New Perioperative Strategies Emerge for High-Risk, Resectable RCC

NEXT ARTICLE

More From BioPortfolio on "New Perioperative Strategies Emerge for High-Risk, Resectable RCC"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cytokine Tumour Necrosis Factor (TNF)
TNF is a compound that is classified as a cytokine which plays a central role in the cellular mechanisms of apoptosis or cell death. However, there are a number of different kinds of TNF, just under twenty, but the family of molecules have very similar a...